Cytosorbents (CTSO) Accounts Payables (2010 - 2026)
Cytosorbents' (CTSO) quarterly Accounts Payables came in at $3.1 million in Q1 2026, down 5.82% YoY from $3.3 million in Q1 2025, and up 9.17% on a QoQ basis from $2.9 million in Q4 2025.
Cytosorbents (CTSO) Accounts Payables (2010 - 2026) Analysis & Trends
Cytosorbents (CTSO) has 17 years of Accounts Payables data on file, last reported at $3.1 million in Q1 2026.
- Quarterly Accounts Payables fell 5.82% year-over-year to $3.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.1 million (down 5.82% YoY) and the FY2025 annual result came in at $2.9 million, down 14.1% from the prior year.
- Accounts Payables advanced to $3.1 million in Q1 2026, from $2.9 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $4.8 million in Q1 2022 to a low of $1.7 million in Q4 2022.
- A 5-year average of $3.0 million and a median of $3.0 million in 2025 frame the typical range for Accounts Payables.
- The widest YoY moves for Accounts Payables: up 187.66% in 2022, down 41.0% in 2022.
- Tracing CTSO's Accounts Payables over 5 years: stood at $1.7 million in 2022, then surged by 129.71% to $3.8 million in 2023, then dropped by 12.16% to $3.3 million in 2024, then decreased by 14.1% to $2.9 million in 2025, then rose by 9.17% to $3.1 million in 2026.
- The last three Accounts Payables figures came in at $3.1 million (Q1 2026), $2.9 million (Q4 2025), and $3.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 4.79 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 1.66 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 2.64 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 1.23 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 210.50 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 3.23 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 2.42 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 344.10 Mn |
| 10 | Cytosorbents | 19.47 Mn | 15.06 Mn | 7.05 Mn | 2.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.00 Mn |
| Mar 31, 2026 | 3.13 Mn |
| Dec 31, 2025 | 2.87 Mn |
| Sep 30, 2025 | 3.04 Mn |
| Jun 30, 2025 | 3.39 Mn |
| Mar 31, 2025 | 3.33 Mn |
| Dec 31, 2024 | 3.34 Mn |
| Sep 30, 2024 | 2.34 Mn |
| Jun 30, 2024 | 3.05 Mn |
| Mar 31, 2024 | 2.40 Mn |
| Dec 31, 2023 | 3.80 Mn |
| Sep 30, 2023 | 3.44 Mn |
| Jun 30, 2023 | 2.84 Mn |
| Mar 31, 2023 | 2.99 Mn |
| Dec 31, 2022 | 1.66 Mn |
| Sep 30, 2022 | 2.35 Mn |
| Jun 30, 2022 | 2.13 Mn |
| Mar 31, 2022 | 4.83 Mn |
| Dec 31, 2021 | 2.81 Mn |
| Sep 30, 2021 | 3.36 Mn |